Community Portal

A place for Clinicians and Healthcare Suppliers to share knowledge and learn more about THE CLINICIAN EXCHANGE

IN THE NEWS

CLINICIAN NEWS

Provided by: Medscape

Breast Tomosynthesis Better Than Mammography?

Published: Thu, 18 Oct 2018 08:53:31 EDT
A simplified, single-view version of digital breast tomosynthesis may increase the detection of breast cancer over standard digital mammography, with lower radiation exposure, say Swedish scientists.
Medscape Medical News

Misdiagnosis of Adult-Onset Type 1 Diabetes Is Common

Published: Thu, 18 Oct 2018 08:53:20 EDT
Study finds patients identified with diabetes after age 30 are often misdiagnosed as having type 2 diabetes and not immediately treated with insulin.
Medscape Medical News

FBT Outreach, Patient Navigation Boost CRC Screening

Published: Thu, 18 Oct 2018 07:20:51 EDT
In a systematic review and meta-analysis of US randomized clinical trials, fecal blood test (FBT) outreach and patient navigation were associated with increased colorectal cancer screening rates.
Medscape Medical News

Immunotherapy Combos: Will Cost Put Them out of Reach?

Published: Thu, 18 Oct 2018 06:46:58 EDT
Immunotherapy has already revolutionized cancer care. Combining various immunotherapies promises even greater success, but will the already high cost of these therapies put combos out of reach?
Medscape Medical News
Displaying results 9-12 (of 20)
 1 - 2 - 3 - 4 - 5 

HEALTHCARE SUPPLIER NEWS

Improving cancer immunotherapy by controlling RNA expression

Published: Wed, 17 Oct 2018 10:07:14 +0000
Scientists have previously managed to control the strength and timing of expression for DNA-based gene therapies, and a group of MIT researchers have now found a way via gene circuit to control the expression of RNA, which they're applying to cancer immunotherapy.

ICER weighs plan to offer trial design advice to pharma companies, for a price

Published: Tue, 16 Oct 2018 17:55:07 +0000
The Institute for Clinical and Economic Review (ICER)—an independent source for information on the cost-effectiveness of new, cutting-edge drugs and big-ticket therapies—is considering charging biotech companies for early scientific advice and direct guidance in clinical trial design.

As U.K. politicians fret Brexit will ‘decimate medical research,’ AstraZeneca sticks to R&D plan

Published: Tue, 16 Oct 2018 13:14:17 +0000
AstraZeneca’s reiteration of its previously announced freeze on investments in U.K. manufacturing has caused alarm among politicians. In the fevered pre-Brexit environment, pro-Remain politicians saw the reiteration of an old position as evidence the split from the U.K. will decimate life science research.  

Nearing phase 3, resTORbio posts new data on infection drug 

Published: Tue, 16 Oct 2018 12:28:12 +0000
ResTORbio has shared additional data from a phase 2b trial of RTB101 in patients with respiratory tract infections. The analyses provide further evidence of the effect the TORC1 inhibitor has on the incidence of RTIs and urinary tract infections in high-risk elderly patients.
Displaying results 9-12 (of 25)
 1 - 2 - 3 - 4 - 5 - 6 - 7 
1-800-4-the-clinx

Clinician Owned and Veteran Owned

copyright 2017 THE CLINICIAN EXCHANGE. Privacy Policy
Top